Cargando…
The Notch signaling pathway: a potential target for cancer immunotherapy
Dysregulation of the Notch signaling pathway, which is highly conserved across species, can drive aberrant epigenetic modification, transcription, and translation. Defective gene regulation caused by dysregulated Notch signaling often affects networks controlling oncogenesis and tumor progression. M...
Autores principales: | Li, Xinxin, Yan, Xianchun, Wang, Yufeng, Kaur, Balveen, Han, Hua, Yu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155406/ https://www.ncbi.nlm.nih.gov/pubmed/37131214 http://dx.doi.org/10.1186/s13045-023-01439-z |
Ejemplares similares
-
Targeting the RNA m(6)A modification for cancer immunotherapy
por: Li, Xinxin, et al.
Publicado: (2022) -
Notch Signaling Pathway and Human Placenta
por: Zhao, Wei-Xiu, et al.
Publicado: (2012) -
Notch signaling pathway: a new target for neuropathic pain therapy
por: Zhang, Yan, et al.
Publicado: (2023) -
Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies
por: Sorrentino, Claudia, et al.
Publicado: (2019) -
Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development
por: You, Weon-Kyoo, et al.
Publicado: (2023)